Table II.

A total of 141 DEGs were identified from three profile datasets, including 55 upregulated and 86 downregulated genes in bladder cancer compared with normal tissues.

DEGs	Genes name
Upregulated	TPX2, CDK1, SAPCD2, AURKA, AURKB, PAFAH1B3, CELSR3, TYMS, MCM5, MELK, CCNA2, CDCA5, CKS2, CENPE, TACC3, CCNB2, PRC1, CDT1, CEP55, CDC45, NT5DC2, MCM2, TMEM74B, DLGAP5, RAD51AP1, CKAP2L, KIAA0101, SHMT2, KIF11, ASF1B, KIF2C, CENPA, CDC20, CENPN, BUB1, POLQ, TRIP13, TROAP, TK1, ASPM, SLC7A5, TOP2A, SLC16A3, CA2, HJURP, HMMR, KIF20A, TTK, NCAPG, SLC52A2, CENPM, FAM64A, CENPF, NUSAP1, CDCA8
Downregulated	CPXM2, MSRB3, LIMS2, CNN1, PALLD, HLA-DRA, CLEC3B, STON1, NDNF, FHL1, SORBS2, PLSCR4, CSRP1, ANKDD1A, PLAC9, LGALS4, RNF150, LAMC3, PDK4, REEP1, EFEMP1, BIN1, AXL, TCEAL2, RASL12, IGFBP6, P3H2, PID1, P2RX1, SRPX, ACACB, PGM5, PRAC1, GSTM5, SOBP, SH3GL2, PLPPR4, CYBRD1, SYNM, C2orf40, CFD, RNASE4, WLS, HSPB6, FAM129A, DACT3, CFH, FLNC, ANTXR2, ABCA8, LMOD1, ZBTB16, KCNMB1, DES, MYH11, KBTBD11, CPED1, PRICKLE2, FERMT2, DPT, MFAP4, MGLL, SCARA5, SDPR, SORBS1, CYGB, KLHL13, FGF9, TSHZ3, SPARCL1, ITM2A, COX7A1, ACTG2, TMOD1, TGFBR2, PCP4, FAM107A, GPX3, PTGS1, CASQ2, LPAR1, MAMDC2, ACOX2, EVA1C, NDN, FBLN5

DEGs, differentially expressed genes.